Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

Journal of Hypertension

Volumn 27, Issue SUPPL. 6, 2009, Pages

  Paulis, Ludovit ^a,b,c   Pechanova, Olga ^c,d   Zicha, Josef ^d   Krajcirovicova, Kristina ^b   Barta, Andrej ^c   Pelouch, Vaclav ^e   Adamcova, Michaela ^e   Simko, Fedor ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Physics and Informatics   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Collagen; Fibrosis; Hydroxyproline; Hypertension; Hypertrophy; Melatonin; N G nitro l arginirte methyl ester; Nitric oxide

Indexed keywords

ALKADIENE; COLLAGEN; CONJUGATED DIENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYPROLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEMODYNAMICS; HYPERTENSION; MALE; NON INVASIVE PROCEDURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT;

EID: 70349297077     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000358831.33558.97     Document Type: Article

References (31)

1. Alfakih K, Reid S, Hall A, Sivananthan MU. The assessment of left ventricular hypertrophy in hypertension. J Hypertens 2006; 24:1223-1230. (Pubitemid 43948316)
2. Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A. Left ventricular hypertrophy and cardiovascular risk stratification: impact and costeffectiveness of echocardiography in recently diagnosed essential hypertensives. J Hypertens 2006; 24:1671-1677. (Pubitemid 44162471)
3. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 2008; 26:1602-1611.
4. Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishino H, Koike H, Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens 1987; 9:1121-1131.
5. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM, Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43:192-197. (Pubitemid 38174173)
6. Simko F, Paulis L Melatonin as a potential antihypertensive treatment. J Pineal Res 2007; 42:319-322. (Pubitemid 46581667)
7. Pechanova O, Bernatova I, Pelouch V, Simko F. Protein remodeling of the heart in NO deficient hypertension: the effect of Captopril. J Mol Cell Cardiol 1997; 29:3365-3374. (Pubitemid 28039370)
8. Pelouch V, Milerova M, Ostadal B, Samanek M, Hucin B, Protein profiling of human atrial and ventricular musculature: the effect of normoxaemia and hypoxamenia in congenital heart diseases. Physiol Res 1993; 42:236-242.
9. Pelouch V, Kolar F, Khuchua ZA, Elizarova GV, Milerova M, Ostadal B, Saka VA. Cardiac phosphocreatine deficiency induced by GPA during postnatal development in rat. Mol Cell Biochem 1996; 163:67-76. (Pubitemid 26421487)
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
11. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29:225-229. (Pubitemid 26142071)
12. Kogure K, Watson R, Busto R, Abe K. Potentiation of lipid peroxides by ischemia in rat brain. Neurochem Res 1982; 7:437-453. (Pubitemid 12037072)
13. Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, et al. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 2008; 31:793-803. (Pubitemid 351772871)
14. Kasal DA, Neves MF, Oigman W, Mandarim-de-Lacerda CA, Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor. Histol Histopathol 2008; 23:1241-1248.
15. Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, et al. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. Eur J Pharmacol 2006; 542:141-147. (Pubitemid 44066358)
16. Simko F, Matuskova J, Luptak I, Pincikova T, Krajcirovicova K, Stvrtina S, et al. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Physiol Res 2007; 56 (Suppl. 2):S25-S32.
17. Bernatova I, Pechanova O, Simko F. Effect of Captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 1999; 84:1095-1105.
18. Simko F, Matuskova J, Luptak I, Krajcirovicova K, Kucharska J, Gvozdjakova A, et al. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life Sci 2004; 74:1 211-1224. (Pubitemid 38022060)
19. Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, et al. Effect of melatonin, Captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertens 2009; 27 (Suppl. 6):S5-S10.
20. Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res 2007; 56:671-684.
21. Pechanova O, Zicha J, Paulis L, Zenebe W, Dobesova Z, Kojsova S, et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007; 561:129-136. (Pubitemid 46435853)
22. Reiter RJ. Melatonin. Lowering the high price of free radicals. News Physiol Sci 2000; 15:246-1225
23. Ghosh G, De K, Maity S, Bandyopadhyay D, Bhattacharya S, Reiter RJ, Bandyopadhyay A. Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res 2007; 42:71-82. (Pubitemid 44924328)
24. Ruiz-Hurtado G, Fernandez-Velasco M, Mourelle M, Delgado C. LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension 2007; 50:1049-1056. (Pubitemid 350172926)
25. Simko F. Left ventricular hypertrophy regression as a process with variable biological implications. Can J Cardiol 1996; 12:507-513. (Pubitemid 26172462)
26. Weber K. Cardioreparation in hypertensive heart disease. Hypertension 2001; 38:588-591.
27. Simko F. Pathophysiological principles of the relation between myocardial hypertrophy of the left ventricle and its regression. Physiol Res 1994; 43:259-266.
28. Mizrak B, Parlakpinar H, Acet A, Turkoz Y. Effects of pinealectomy and exogenous melatonin on rat hearts. Acta Histochem 2004; 106:29-36. (Pubitemid 38280212)
29. Paulis L, Vazan R, Simko F, Pechanova O, Styk J, Babal P, Janega P. Morphological alterations and NO-synthase expression in the heart after continuous light exposure of rats. Physiol Res 2007; 56 (Suppl. 2):S71-S76.
30. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, et al. Stretchinduced programmed myocyte cell death. J Clin Invest 1995; 96:2247-2259.
31. Reddy HK, Tjahja IE, Campbell SE, Janicki JS, Hayden MR, Tyagi SC. Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 2004; 264:183-191.